-The Indian Express Mumbai: The Bombay High Court on Wednesday granted anticipatory bail to a senior bank official accused of molesting a teenage girl, saying that "he is a high-profile person and has been exposed to humiliation already". Joginder Singh, a deputy general manager with the Oriental Bank of Commerce, was booked by the police for allegedly molesting a 16-year-old girl in the lift of his residential building in Vile Parle on...

-The Economic Times MUMBAI: India's strong stance on minor drug innovations could reverberate in national parliaments and courthouses of the developed world as Australia, the EU and Canada get ready to discuss and ban patent protection for frivolous improvements. A top Australian government body on Wednesday asked for changes in its patent laws relating to drugs saying that the indiscriminate grant of patents to incremental innovations should be checked and that...

-The Indian Express Chandigarh: Slamming the Punjab government for sponsoring "xenophobia", the Punjab and Haryana High Court on Wednesday set aside its "discriminatory" rules, wherein it had allowed additional weightage to rural students for government jobs. A Full Bench comprising Justices Hemant Gupta, Ajay Tewari and R N Raina held the rules framed by Punjab as "illegal, unconstitutional" and beyond its "legislative competence". "State sponsored xenophobia is constitutional anathema and the principle...

-The Hindu The lesson from the Supreme Court ruling on Gleevec is that pharmaceutical multinational corporations need to focus research on genuine innovations rather than on ways to evergreen their patents The much awaited Supreme Court judgment on Gleevec has been delivered. Novartis has failed in reversing the rejection of its patent. And, predictably - like a scratched record - there have been suggestions that pharma investments in India will dry...

-The Economic Times To ensure access to healthcare for all, India must harness innovation in discovering drugs, in developing therapeutics and in delivering affordable healthcare. It is in the light of these facts that one should evaluate the impact of the Indian Supreme Court's ruling in the case involving patent protection for Novartis AG's cancer drug, Glivec. Glivec was the first-of-its-kind cancer drug for leukaemia patients with patent protection in nearly 40...